Precision Biosciences Inc (DTIL) Stock Price, Quote & News

Company Profile

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with t...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 314 5512

Fax: 480 393 5553

Website: precisionbiosciences.com

Address:

302 East Pettigrew St., Suite A-100, Durham, United States

JG101 Nov. 16 at 9:01 AM

$DTIL Interesting article.

0 · Reply

Impatient_Investor Nov. 14 at 7:58 PM

$DTIL company management doesn't want the SP to go up so they can loot free shares at lower prices and this is the reason they announced the offering after a very good news. Those guys must be atheists as they dont have fear of god for their wrongdoings.

0 · Reply

schultzeee Nov. 14 at 6:39 PM

$DTIL the weakest, most conservative scenario for HBV and DMD has us valued at $8 to $12 billion.

1 · Reply

thebenchwarmers Nov. 14 at 3:51 PM

$DTIL https://partners.wsj.com/qatar-investment-authority/building-an-investment-ready-ecosystem/why-tomorrows-cures-need-todays-patient-investors/?gaa_at=eafs&gaa_n=AWEtsqdEtxzm_CABGIBb4Eo1gQS2Tk5AiEXZUx4gsmUetoG0nho4-qMoOUSK73XUX6E%3D&gaa_ts=6917528b&gaa_sig=R006n3aRrhBuN07tqYxrIGD5ko66ULlXvGlou7CYXTW2Blnyqi2btMWhlZtNXqm2_L2-UazMPrQfuTfY2lgEZA%3D%3D

0 · Reply

Impatient_Investor Nov. 14 at 6:48 AM

$DTIL

0 · Reply